Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (8r)-6 Beta,7 Beta-epoxy-8-ethyl-3 Alpha((-)-tropoyl)-1 Alpha H, 5 Alpha H-tropanium Bromide
2. Ba 253
3. Ba 253br
4. Ba-253
5. Ba-253br
6. Oxitropium
7. Oxitropium Bromide
8. Oxitropium Iodide, (r)-isomer
9. Oxitropium Iodide, (s)-isomer
10. Oxivent
11. Oxytropium Bromide
12. Tersigat
13. Ventilat
1. Oxitropium Bromide
2. 30286-75-0
3. (9-ethyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 3-hydroxy-2-phenylpropanoate;bromide
4. [(1s,2s,4r,5s)-9-ethyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2s)-3-hydroxy-2-phenylpropanoate;bromide
5. Schembl109688
| Molecular Weight | 412.3 g/mol |
|---|---|
| Molecular Formula | C19H26BrNO4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 411.10452 g/mol |
| Monoisotopic Mass | 411.10452 g/mol |
| Topological Polar Surface Area | 59.1 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 472 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 5 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03B - Other drugs for obstructive airway diseases, inhalants
R03BB - Anticholinergics
R03BB02 - Oxitropium bromide
Global Sales Information
ABOUT THIS PAGE
A Oxitropium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxitropium Bromide, including repackagers and relabelers. The FDA regulates Oxitropium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxitropium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxitropium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxitropium Bromide supplier is an individual or a company that provides Oxitropium Bromide active pharmaceutical ingredient (API) or Oxitropium Bromide finished formulations upon request. The Oxitropium Bromide suppliers may include Oxitropium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Oxitropium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Oxitropium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxitropium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxitropium Bromide GMP manufacturer or Oxitropium Bromide GMP API supplier for your needs.
A Oxitropium Bromide CoA (Certificate of Analysis) is a formal document that attests to Oxitropium Bromide's compliance with Oxitropium Bromide specifications and serves as a tool for batch-level quality control.
Oxitropium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Oxitropium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxitropium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxitropium Bromide EP), Oxitropium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxitropium Bromide USP).
LOOKING FOR A SUPPLIER?
